Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Here’s a few solid ideas to start (not in prioritized order):
- Work with the management to decrease outstanding share count.
- Continue to increase profitability (potentially current strategic state)
- Complete separation from Elite and CEO’s company, Mikah
- Separate CEO & Chairman roles
- Uplist off OTC
- Implement a small recurring buyback that swallows up more than the annual dilution (going back to first point)
- Get some of those big needle movers filed so investors can see the BE study results, products and total market so actual analysis can be done on the pipeline.
- Hire a CFO that sticks around longer than a year.
- Submit financials without need for amendments.
- Build credibility with shareholders by doing what mgmt says company will do (much better than history, still long road ahead). A crushed stock from credibility being hammered is incredibly hard to fix. Financial results will speak for themselves when Elite gets larger products filed, approved & launched. It’s unlikely this will take place in 2024 so you’re looking 2-3 years out due to no big BE studies reported on yet and the time it takes from BE to FDA filing, approval (no CRLs despite Elite having a history of them) and launch.